Apologies hit post too early. OD designation seems very unlikely. If they had a larger trial, and included hand-use, ambulation and removed Anxiety as a measure of efficacy they'd have better luck. Our P2 results weren't *that* strong but our trial design was less than ideal given GI issues, dosage and we've learnt how Daybue works in the real world (slowly increasing dosage) - and that the affect seems to compound with time.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
Apologies hit post too early. OD designation seems very...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.85 |
Change
-0.060(0.30%) |
Mkt cap ! $2.535B |
Open | High | Low | Value | Volume |
$19.88 | $20.07 | $19.73 | $1.564M | 78.62K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 80 | $19.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.85 | 236 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 136 | 19.870 |
6 | 258 | 19.860 |
12 | 1255 | 19.850 |
5 | 279 | 19.840 |
3 | 240 | 19.830 |
Price($) | Vol. | No. |
---|---|---|
19.880 | 242 | 10 |
19.890 | 310 | 6 |
19.900 | 398 | 4 |
19.910 | 254 | 4 |
19.920 | 340 | 6 |
Last trade - 13.41pm 21/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online